Jump to content

Mir-32 microRNA precursor family

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by JCW-CleanerBot (talk | contribs) at 13:26, 3 May 2018 (→References: task, replaced: International journal of oncology → International Journal of Oncology using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

mir-32
Identifiers
Symbolmir-32
RfamRF00666
miRBase familyMIPF0000069
Other data
RNA typemicroRNA
Domain(s)Eukaryota;
PDB structuresPDBe

In molecular biology mir-32 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

See also

References

1.[1] 2.[2] 3.[3] 4.[4] 5.[5] 6.[6] 7.[7] 8.[8] 9.[9] 10.[10] 11.[11] 12.[12] 13.[13] 14.[14] 15.[15] 16.[16] 17.[17] 18.[18] 19.[19] 20.[20]

  1. ^ Mishra, R.; Chhatbar, C.; Singh, S. K. (2012). "HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia". Journal of Neuroinflammation. 9 (1): 131. doi:10.1186/1742-2094-9-131. PMC 3418571. PMID 22709905.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  2. ^ Shin, D.; Howng, S. Y. B.; Ptáček, L. J.; Fu, Y. -H. (2012). "MiR-32 and its target SLC45A3 regulate the lipid metabolism of oligodendrocytes and myelin". Neuroscience. 213: 29–37. doi:10.1016/j.neuroscience.2012.03.054. PMC 3370422. PMID 22521588.
  3. ^ Zhang, S.; Chen, H.; Zhao, X.; Cao, J.; Tong, J.; Lu, J.; Wu, W.; Shen, H.; Wei, Q.; Lu, D. (2012). "REV3L 3′UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility". Oncogene. 32 (2): 242–250. doi:10.1038/onc.2012.32. PMID 22349819.
  4. ^ Jalava, S. E.; Urbanucci, A.; Latonen, L.; Waltering, K. K.; Sahu, B.; Jänne, O. A.; Seppälä, J.; Lähdesmäki, H.; Tammela, T. L. J.; Visakorpi, T. (2012). "Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer". Oncogene. 31 (41): 4460–4471. doi:10.1038/onc.2011.624. PMID 22266859.
  5. ^ Yu, X. F.; Zou, J.; Bao, Z. J.; Dong, J. (2011). "MiR-93 suppresses proliferation and colony formation of human colon cancer stem cells". World Journal of Gastroenterology. 17 (42): 4711–4717. doi:10.3748/wjg.v17.i42.4711. PMC 3233678. PMID 22180714.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ Leite, K. R. M.; Tomiyama, A.; Reis, S. T.; Sousa-Canavez, J. M.; Sañudo, A.; Camara-Lopes, L. H.; Srougi, M. (2011). "MicroRNA expression profiles in the progression of prostate cancer—from high-grade prostate intraepithelial neoplasia to metastasis". Urologic Oncology: Seminars and Original Investigations. 31: 796–801. doi:10.1016/j.urolonc.2011.07.002. PMID 21880514.
  7. ^ Wu, W.; Luo, F.; Li, Q.; Xu, M.; Feng, D.; Zhang, G.; Wu, W. (2011). "Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance". Oncology Reports. 26 (6): 1431–1439. doi:10.3892/or.2011.1437. PMID 21874264.
  8. ^ Gocek, E.; Wang, X.; Liu, X.; Liu, C. -G.; Studzinski, G. P. (2011). "MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis". Cancer Research. 71 (19): 6230–6239. doi:10.1158/0008-5472.CAN-11-1717. PMID 21816906.
  9. ^ Scian, M. J.; Maluf, D. G.; David, K. G.; Archer, K. J.; Suh, J. L.; Wolen, A. R.; Mba, M. U.; Massey, H. D.; King, A. L.; Gehr, T.; Cotterell, A.; Posner, M.; Mas, V. (2011). "MicroRNA Profiles in Allograft Tissues and Paired Urines Associate with Chronic Allograft Dysfunction with IF/TA". American Journal of Transplantation. 11 (10): 2110–2122. doi:10.1111/j.1600-6143.2011.03666.x. PMC 3184368. PMID 21794090.
  10. ^ Mahn, R.; Heukamp, L. C.; Rogenhofer, S.; Von Ruecker, A.; Müller, S. C.; Ellinger, J. R. (2011). "Circulating microRNAs (miRNA) in Serum of Patients with Prostate Cancer". Urology. 77 (5): 1265.12e9–16. doi:10.1016/j.urology.2011.01.020. PMID 21539977.
  11. ^ Dacic, S.; Kelly, L.; Shuai, Y.; Nikiforova, M. N. (2010). "MiRNA expression profiling of lung adenocarcinomas: Correlation with mutational status". Modern Pathology. 23 (12): 1577–1582. doi:10.1038/modpathol.2010.152. PMID 20818338.
  12. ^ Haflidadóttir, B. S.; Bergsteinsdóttir, K. N.; Praetorius, C.; Steingrímsson, E. K. (2010). Jin, Dong-Yan (ed.). "MiR-148 Regulates Mitf in Melanoma Cells". PLoS ONE. 5 (7): e11574. doi:10.1371/journal.pone.0011574. PMC 2904378. PMID 20644734.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  13. ^ Leite, K. R. M.; Canavez, J. M. S.; Reis, S. T.; Tomiyama, A. H.; Piantino, C. B.; Sañudo, A.; Camara-Lopes, L. H.; Srougi, M. (2011). "MiRNA analysis of prostate cancer by quantitative real time PCR: Comparison between formalin-fixed paraffin embedded and fresh-frozen tissue". Urologic Oncology: Seminars and Original Investigations. 29 (5): 533–537. doi:10.1016/j.urolonc.2009.05.008. PMID 19734068.
  14. ^ Petillo, D.; Kort, E. J.; Anema, J.; Furge, K. A.; Yang, X. J.; Teh, B. T. (2009). "MicroRNA profiling of human kidney cancer subtypes". International Journal of Oncology. 35 (1): 109–114. doi:10.3892/ijo_00000318. PMID 19513557.
  15. ^ Guled, M.; Lahti, L.; Lindholm, P. M.; Salmenkivi, K.; Bagwan, I.; Nicholson, A. G.; Knuutila, S. (2009). "CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis". Genes, Chromosomes and Cancer. 48 (7): 615–623. doi:10.1002/gcc.20669. PMID 19396864.
  16. ^ Mascaux, C.; Laes, J. F.; Anthoine, G.; Haller, A.; Ninane, V.; Burny, A.; Sculier, J. P. (2008). "Evolution of microRNA expression during human bronchial squamous carcinogenesis". European Respiratory Journal. 33 (2): 352–359. doi:10.1183/09031936.00084108. PMID 19010987.
  17. ^ Pichiorri, F.; Suh, S. -S.; Ladetto, M.; Kuehl, M.; Palumbo, T.; Drandi, D.; Taccioli, C.; Zanesi, N.; Alder, H.; Hagan, J. P.; Munker, R.; Volinia, S.; Boccadoro, M.; Garzon, R.; Palumbo, A.; Aqeilan, R. I.; Croce, C. M. (2008). "MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis". Proceedings of the National Academy of Sciences. 105 (35): 12885–12890. doi:10.1073/pnas.0806202105. PMC 2529070. PMID 18728182.
  18. ^ Ambs, S.; Prueitt, R. L.; Yi, M.; Hudson, R. S.; Howe, T. M.; Petrocca, F.; Wallace, T. A.; Liu, C. -G.; Volinia, S.; Calin, G. A.; Yfantis, H. G.; Stephens, R. M.; Croce, C. M. (2008). "Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer". Cancer Research. 68 (15): 6162–6170. doi:10.1158/0008-5472.CAN-08-0144. PMC 2597340. PMID 18676839.
  19. ^ Palmieri, A.; Pezzetti, F.; Brunelli, G.; Martinelli, M.; Scapoli, L.; Arlotti, M.; Masiero, E.; Carinci, F. (2008). "Medpor regulates osteoblast's microRNAs". Bio-medical materials and engineering. 18 (2): 91–97. PMID 18408260.
  20. ^ Choong, M. L.; Yang, H. H.; McNiece, I. (2007). "MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis". Experimental Hematology. 35 (4): 551–564. doi:10.1016/j.exphem.2006.12.002. PMID 17379065.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mir-32_microRNA_precursor_family&oldid=839443826"